SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-010043
Filing Date
2016-11-14
Accepted
2016-11-14 16:02:46
Documents
48
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20160930x10q.htm 10-Q 1251168
2 EX-31.1 axsm-20160930ex311c30009.htm EX-31.1 10712
3 EX-31.2 axsm-20160930ex3128888bf.htm EX-31.2 10500
4 EX-32.1 axsm-20160930ex321c8b137.htm EX-32.1 5917
5 EX-32.2 axsm-20160930ex322c9b126.htm EX-32.2 5888
  Complete submission text file 0001558370-16-010043.txt   3589866

Data Files

Seq Description Document Type Size
6 EX-101.INS axsm-20160930.xml EX-101.INS 627351
7 EX-101.SCH axsm-20160930.xsd EX-101.SCH 22240
8 EX-101.CAL axsm-20160930_cal.xml EX-101.CAL 24276
9 EX-101.DEF axsm-20160930_def.xml EX-101.DEF 65135
10 EX-101.LAB axsm-20160930_lab.xml EX-101.LAB 238717
11 EX-101.PRE axsm-20160930_pre.xml EX-101.PRE 164962
Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 161994696
SIC: 2834 Pharmaceutical Preparations